Pharmaceutical Development of Innovative Russian Radiopharmaceuticals Based on Bispecific Nanoantibodies to Gitr and Ctla-4 for the Theranostics of Oncological Diseases. Maystrenko, D., Stanzhevsky, A. A., Sergunova, K. A., Shatik, S. V., Antuganov, D. O., Shehadat, R. I. A., Sysoev, D., Nadporozhsky, M. S., Konevega, A. L., Trashkov, A. P., Molchanov, O. E., Chipiga, L. A., & Vodovatov, A. Nanobiotechnology Reports, 18(4):650–657, Pleiades Publishing Ltd, August, 2023.
Pharmaceutical Development of Innovative Russian Radiopharmaceuticals Based on Bispecific Nanoantibodies to Gitr and Ctla-4 for the Theranostics of Oncological Diseases [link]Paper  doi  bibtex   
@Article{Maystrenko2023,
  author    = {D. Maystrenko and A. A. Stanzhevsky and K. A. Sergunova and S. V. Shatik and D. O. Antuganov and R. I. Al Shehadat and D. Sysoev and M. S. Nadporozhsky and A. L. Konevega and A. P. Trashkov and O. E. Molchanov and L. A. Chipiga and A. Vodovatov},
  journal   = {Nanobiotechnology Reports},
  title     = {Pharmaceutical Development of Innovative Russian Radiopharmaceuticals Based on Bispecific Nanoantibodies to Gitr and Ctla-4 for the Theranostics of Oncological Diseases},
  year      = {2023},
  issn      = {2635-1684},
  month     = aug,
  number    = {4},
  pages     = {650--657},
  volume    = {18},
  doi       = {10.1134/S2635167623600165},
  publisher = {Pleiades Publishing Ltd},
  url       = {https://www.semanticscholar.org/paper/2a778eafc64fcf1bdf62cb5919603ae5497ebb4c},
  venue     = {Nanobiotechnology Reports},
}

Downloads: 0